How to Test for HPV in Men

There's no FDA-approved HPV test for men. HPV tests aren't recommended to screen men, and no swab or blood test detects the virus in a man without symptoms. A clinician diagnoses by examining visible warts. If you're worried about exposure, get a visual exam.

Why there's no standard HPV test for men

HPV is the most common STI, and the science of testing for it was built around the cervix CDC, About HPV. The available molecular HPV tests look for high-risk viral DNA in cervical cells, validated to catch precancer in tissue that can be sampled and watched over time. Men have no equivalent screening site that a test has been proven to help, so routine HPV testing isn't recommended for men, adolescents, or women under age 30.

People blur two things together. Low-risk types (6 and 11) cause genital warts; high-risk types (16, 18, and others) cause cancers, and the wart types don't cause cancer. A man's real concern is usually one or the other, and neither is best answered by an HPV swab. Warts are diagnosed by looking at them. An HPV test wouldn't confirm anything or change how a wart is managed.

How HPV is actually detected

For men, detection is clinical. A clinician inspects the penis, scrotum, groin, and anal area for warts — soft, flesh-colored or gray growths that can be flat, raised, or cauliflower-like, singly or in clusters. They may apply a dilute acetic-acid solution that turns some lesions white, making subtle warts easier to see. That exam is enough to diagnose genital warts.

Men often expect a urine HPV test, a blood test, or HPV added to a general STD panel. None of those exist for routine use. For women, the virus is found through cervical screening, which is separate from a general STD panel CDC, Pink Book, and no parallel screening sample is collected from men. If something looks suspicious for cancer rather than a wart, the next step is a biopsy of that specific lesion.

When to "test" after exposure — the window question

There's no testing window for HPV because there's no test to time. The CDC doesn't set a fixed window: warts can appear months or years after you acquire HPV, and the time of acquisition can't be definitively determined. You can't pin an infection to one partner or one date, and waiting a set number of days doesn't unlock a useful result.

If you notice a new bump, get it looked at promptly. For the other infections that do have clear testing windows after a risky encounter, see our guide on when to test after exposure, and you can get tested for those at the same visit.

Who should actually be screened

Screening recommendations are sex- and site-specific, which is where people get confused:

• Men with no symptoms: No routine HPV screening exists. There's nothing to order, and asking for an HPV test on a panel won't add a valid result.
• Women: Cervical screening is the route HPV is checked. The USPSTF (2018, Grade A) recommends cytology every three years for ages 21–29, and for ages 30–65 either cytology every three years, high-risk HPV testing alone every five years, or co-testing every five years USPSTF, 2018. More recent guidance moves toward starting at 25 with a primary HPV test every five years, since most HPV clears within two years and HPV testing catches more real precancer with fewer visits ACS.
• Anal screening: CDC's 2021 guidance found data insufficient to recommend routine anal cytology, even for men who have sex with men or people with HIV. That position predates the 2022 ANCHOR trial, which showed treating anal high-grade lesions reduced anal cancer in people with HIV; some specialty groups now suggest periodic anal Pap for high-risk groups where high-resolution anoscopy referral exists. It's not a blanket CDC recommendation, so discuss it individually if you're in a high-risk group.

What the visit (or an at-home kit) is like, and what it costs

For a man, the appointment is short: you describe what you've noticed, the clinician examines the area, and they tell you whether it looks like a wart. There's no swab to send off and no HPV result to wait for. If a lesion looks atypical, they may snip a tiny sample to biopsy.

Be skeptical of at-home "HPV test" kits marketed to men. The at-home HPV kits that exist are self-collected cervico-vaginal samples for women. There's no validated male version, so a kit promising to detect HPV in a man isn't backed by current guidance. If you're comparing legitimate STI testing options for the infections that do have tests, you can compare testing providers there.

Reading your results

Because there's no male HPV test, there's no positive-or-negative HPV result to interpret for men. What you get is a visual finding: warts present, or none seen. A wart diagnosis means you have a low-risk HPV type, which is reassuring on the cancer front since wart types don't cause cancer. No visible warts doesn't mean you're virus-free; HPV is often silent and clears on its own, and in about nine out of ten cases it's gone within two years without health problems.

On the women's side, a result is read differently. A positive high-risk HPV test isn't a cancer diagnosis; it flags cells worth watching, since most infections clear and only persistent high-risk infection drives cancer risk over years.

What to do if you have warts

Warts are treatable. Treatment clears the visible growths but doesn't eradicate the virus. A clinic can freeze them, or you apply a prescription cream at home over several weeks. No single method is clearly best, and because the virus stays, warts can recur, so treating them doesn't make you non-infectious. For the full treatment walkthrough, and to tell anal warts from something benign, see anal warts vs hemorrhoids.

When to see a clinician

Get checked if you notice any new bumps, growths, or changes in the genital or anal area, or if a partner is diagnosed with HPV-related disease. See someone promptly for a lesion that bleeds, hardens, ulcerates, grows quickly, or doesn't behave like a typical wart — those features prompt a biopsy to rule out cancer. HPV's cancer toll reaches beyond the cervix: it causes over 90% of anal cancers and about 70% of throat (oropharyngeal) cancers, and oropharyngeal cancer has now overtaken cervical as the most common HPV-related cancer in the US NCI, so persistent throat symptoms or a neck lump also warrant evaluation.

Prevention beats any test

Since there's no screening for men, the strongest move is vaccination. Given at the recommended ages, the HPV vaccine can prevent more than 90% of HPV-caused cancers American Cancer Society. The shot used in the US today is Gardasil 9, covering nine types (6, 11, 16, 18, 31, 33, 45, 52, and 58). Types 6 and 11 cause more than 90% of genital warts, and types 16 and 18 cause about 66% of cervical cancers, with five more high-risk types adding roughly another 15%.

The vaccine prevents infection; it doesn't treat one. Gardasil 9 protects against future infection but won't clear an infection or warts you already have, and vaccinated people still need cervical screening where it applies. Adults can still benefit — see the hpv vaccine for adults guide and, if you're weighing the rules and requirements, hpv vaccine - mandatory or not?.

How HPV in men compares to women's screening